Technical Analysis for VKTX - Viking Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 6.68 1.52% 0.10
VKTX closed down 0.15 percent on Tuesday, October 22, 2019, on 52 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical VKTX trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 1.52%
Boomer Sell Setup Bearish Swing Setup 1.52%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.52%
1,2,3 Retracement Bearish Bearish Swing Setup 1.37%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.37%
Inside Day Range Contraction 1.37%
20 DMA Resistance Bearish 2.22%
1,2,3 Retracement Bearish Bearish Swing Setup 2.22%
180 Bearish Setup Bearish Swing Setup 2.22%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.22%

Older signals for VKTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which has completed Phase I trial for the treatment of cancer cachexia, a disease characterized by an uncontrolled decline in muscle mass. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as other preclinical programs for metabolic diseases and anemia. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Medicine Health Biopharmaceutical Cancer Medical Specialties Disease Diabetes Medication Treatment Of Cancer Anemia Hepatitis Geriatrics Metabolic Diseases Dyslipidemia Non Alcoholic Fatty Liver Disease Steatohepatitis Lipid Disorders Rehabilitation Medicine
Is VKTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.69
52 Week Low 6.15
Average Volume 1,217,479
200-Day Moving Average 7.9887
50-Day Moving Average 6.8997
20-Day Moving Average 6.6888
10-Day Moving Average 6.5175
Average True Range 0.2962
ADX 32.45
+DI 10.1089
-DI 22.3414
Chandelier Exit (Long, 3 ATRs ) 6.3764
Chandelier Exit (Short, 3 ATRs ) 7.0386
Upper Bollinger Band 7.0932
Lower Bollinger Band 6.2844
Percent B (%b) 0.37
BandWidth 12.091855
MACD Line -0.1307
MACD Signal Line -0.1421
MACD Histogram 0.0115
Fundamentals Value
Market Cap 182.25 Million
Num Shares 27.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -7.93
Price-to-Sales 0.00
Price-to-Book 10.84
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.87
Resistance 3 (R3) 6.86 6.75 6.82
Resistance 2 (R2) 6.75 6.68 6.76 6.80
Resistance 1 (R1) 6.67 6.64 6.62 6.68 6.79
Pivot Point 6.56 6.56 6.54 6.57 6.56
Support 1 (S1) 6.48 6.49 6.43 6.49 6.37
Support 2 (S2) 6.37 6.45 6.38 6.36
Support 3 (S3) 6.29 6.37 6.34
Support 4 (S4) 6.30